Patients with psoriasis who had low body surface area (BSA) involvement experienced similarly poor QOL and symptom burden compared to patients with higher BSA.

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

Coming off a Super Bowl victory, Eagles tight end Dallas Goedert sat down with Newsweek to discuss his plaque psoriasis and ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% of whom were women. The majority underwent gastric bypass surgery (75.1%), ...

ALEXANDRIA, VA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- ● The NPF Seal of Recognition highlights products that prove a commitment to being safe and non-irritating for people with psoriasis ...

Last week, the FDA approved Arcutis Biotherapeutics' roflumilast foam 0.3% to treat plaque psoriasis of the scalp and body in patients aged 12 years and older, adding a nonsteroidal, once-daily, ...

The best spray sunscreens are a handy addition to any skin-care stash, offering a convenient, refreshing way to spritz your way to sun safety all throughout the day, whether you’re biking, beach-bound ...

In clinical trials, ZORYVE foam 0.3% demonstrated significant improvements in signs and symptoms of psoriasis on both the body and scalp, with positive results across all efficacy endpoints, and ...

To be included, all patients were diagnosed with plaque-type psoriasis with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, an Investigator’s Global Assessment score of 3 or greater ...